Bringing the fundamentals into focus…
Back to Fennec Pharmaceuticals Inc.
How Fennec Pharmaceuticals Inc. stacks up
FENC · against 393 other Healthcare companies of similar size
Profitability
21/ 100
Near the bottom of its peers.
Ranked #293 of 394 · scores higher than 24% of peers
Bars: peers in each 10-point band of the profitability score53 peers with a profitability score of 20–29, including FENC · Click a bar to see the companies
Why profitability scores 21?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, return on invested capital and operating margin, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 100% of peers. Return on assets: -12850.3% vs peer median 1.7%
- a lower return on invested capital: weaker than 70% of peers. Return on invested capital: -4.3% vs peer median 4.7%
- a thinner operating margin: weaker than 69% of peers. Operating margin: -1.9% vs peer median 7.1%
Metric by metric
Position: dot = FENC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | FENC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 363 reported | -4.3% | 0.7% | 40% | 33% | |
| Operating marginHigher is better · 365 reported | -1.9% | 3.3% | 40% | 33% | |
| Return on assetsHigher is better · 392 reported | -12850.3% | 0.1% | 0% | 33% | |
| Return on equityHigher is better · 371 reported | -18.6% | -0.5% | 34% | Context only | |
| Gross marginHigher is better · 412 reported | 93.7% | 37.1% | 94% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around FENC| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 293 | 1.6B HKD (≈$209M) | 21 | 54 | |
| 293 | 560M USD | 21 | 42 | |
| 293 | 365M USD | 21 | 41 | |
| 293 | 486M USD | 21 | 16 | |
| 293 | 375M USD | 21 | 46 | |
| 293 | 285M USD | 21 | 38 | |
| 299 | 222M USD | 20 | 31 | |
| 299 | 238M USD | 20 | 41 | |
| 299 | 299M USD | 20 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score